CNBC: Investing

AUGUST 6, 2025

Markets Currencies Cryptocurrency Futures & Commodities Bonds Funds & ETFs Business Economy Finance Health & Science Media Real Estate Energy Climate Transportation Industrials Retail Wealth Sports Life Small Business Investing Personal Finance Fintech Financial Advisors Options Action ETF Street Buffett Archive Earnings Trader Talk Tech (..)

Bank

CNBC: Investing

AUGUST 6, 2025

The bank upgraded shares of the medical technology provider to outperform from sector perform. Analyst Conor McNamara accompanied the move by raising his price target to $87 per share from $72.

Medical

Razorpay

MARCH 11, 2024

Be it traveling abroad for education, medical treatment, business, or pleasure, things have become a lot smoother than before. LRS enables diversification of investment portfolios by allowing individuals to invest in foreign assets such as stocks, bonds, and real estate. What are the benefits of Liberalised Remittance Scheme?

Accountant

Mergers and Inquisitions

NOVEMBER 1, 2023

The short answer to #1 is that healthcare private equity firms operate in specific verticals with stable-ish cash flows, such as healthcare services, nursing facilities, medical devices, equipment, and healthcare IT. They do not invest in risky biotech startups attempting to cure cancer (at least not within their traditional PE portfolios).

Private Equity

Cooley M&A

JANUARY 25, 2023

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions.

M&A

Cooley M&A

JANUARY 23, 2024

Strategic innovation Strategic acquirers are feeling more pressure to consummate bolt-on acquisitions in order to round out their portfolios, enter new markets and fill innovation gaps. Moving into Q2 of 2023, roughly 29% of US public biotech companies traded below their cash value.

M&A

Growth Business

SEPTEMBER 13, 2023

Investment range: £50,000 – £3m Sectors: fintech, insurtech, regtech, digital health and medical technology, artificial intelligence and machine learning, consumer services, digital media, semiconductors and displays, cybersecurity, enterprise software, autonomous systems and human computer interfaces, novel materials and quantum technology.

Capital

Cooley M&A

JANUARY 25, 2024

In one of the most high-profile examples of this increased scrutiny, the US Federal Trade Commission (FTC) attempted to block Horizon Therapeutics’ $29.3 Out of the Nordic countries, companies such as Novo Nordisk capitalized on massive revenue boosts from weight-loss medications (Wegovy and Ozempic) with multibillion-dollar acquisitions.

M&A

Cooley M&A

JANUARY 25, 2023

Similarly, we expect sponsors to actively pursue carve out opportunities – like Francisco Partners’ carve out acquisition of the data and analytics assets from IBM’s Watson Health business – in 2023 as tech giants streamline their portfolios to focus on their core businesses.

M&A

Cooley M&A

JANUARY 20, 2022

approved prescription cannabidiol medicine to its portfolio. For example, early in 2021, Zimmer Biomet Holdings announced that it would spin off its spine and dental businesses into a new publicly traded company as a way to “optimize resource allocation” among its remaining businesses. driven assets.

M&A

Financial Times - Banking

AUGUST 4, 2025

Iran proposes slashing four zeros from currency Swiss shares slide on first trading day since Trump’s 39% tariff Figma’s IPO was fine, actually Climate Opinion Sections Opinion Home Columnists The FT View The Big Read Lex Obituaries Letters Most Read The AI job cuts are accelerating How bad was the jobs report? © THE FINANCIAL TIMES LTD 2025.

Trading

Focus Investment Banking

FEBRUARY 11, 2025

Overcoming Marketplace Uncertainty Rising interest rates introduced a difficult environment for private equity recapitalizations (where private equity groups sell a portfolio company to another buyer), so few of the older PE-backed ophthalmology organizations traded hands over the last few years. dental).

Private Equity

Mergers and Inquisitions

MARCH 5, 2025

Example Biotech Trades What Makes Biotech Hedge Funds Different? Many biotech stocks are relatively uncorrelated with the broader market because they trade based on catalysts rather than GDP growth, inflation, interest rates, or consumer spending. Of course, many other trades are possible. And What Do They Do?

Funds